Clinical service for personalized cancer drug response evaluation using patient-derived tumor organoids and organ chips. Supports precision medicine treatment selection and optimization.
Manufactured by
Suzhou City, Jiangsu, China
Avatarget Co., Ltd. (Avatarget) is dedicated to R D and production of organs-on-chips, smart equipments, biological reagents, and other products and services, aiming to build a whole-industry-chain ecosystem for organs-on-chips. It also desires to innovate and break through the limitations of traditional animal models and 2D cell models to address species differences and achieve 3D dynamic cultivation of in vitro models. Also, it seeks to create a highly simulated human body micro-environment and enhance the accuracy of experimental data in order to provide precise and effective products and solutions for users in fields such as tumor precision medicine, disease modeling, drug screening, drug evaluation, cosmetics evaluation, regenerative medicine research and space medicine research.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
PreceDo Pharmaceuticals Co.Ltd.
China · 2 relevant products
Yashraj Biotechnology GmbH
Germany · 1 relevant product
BioChain (Beijing) Science & Technology. Inc.
China · 1 relevant product
Accurate International Biotechnology (Guangzhou) Co.,Ltd
China · 2 relevant products
NOROVA
China · 2 relevant products
Diatech Pharmacogenetics srl
Italy · 2 relevant products
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 4 relevant products
Life Medical Diagnostics LLC
United Arab Emirates · 1 relevant product
HEMEX AG
Switzerland · 1 relevant product
Axbio (shenzhen) Co.,LTD
China · 1 relevant product
26 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →6 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 52 closest product alternatives
PreceDo Pharmaceuticals Co.Ltd. · China
A high-throughput drug sensitivity testing platform utilizing renewable primary cancer cells to predict treatment response. This service enables personalized treatment selection through comprehensive chemotherapy and targeted drug profiling.
Yashraj Biotechnology GmbH · Germany
Comprehensive service for discovering and identifying new cancer biomarkers in human serum and plasma samples to advance precision medicine and diagnostics.
BioChain (Beijing) Science & Technology. Inc. · China
A targeted blood-based early detection service for specific cancer types utilizing gene methylation biomarkers. This clinical testing service is performed by BioChain's certified medical laboratory.
PreceDo Pharmaceuticals Co.Ltd. · China
High-throughput DNA sequencing service for clinical sample analysis and genomic profiling. This service enables identification of disease-associated genetic variants for precision medicine applications.
Accurate International Biotechnology (Guangzhou) Co.,Ltd · China
A comprehensive clinical diagnostic service combining organoid-based drug sensitivity testing with next-generation sequencing analysis. This integrated approach provides personalized cancer treatment recommendations by identifying both drug responses and genomic profiles to optimize therapeutic outcomes.
NOROVA · China
A service that establishes three-dimensional in vitro cell culture models from patient-derived fresh tumor tissue, creating stereoscopic models with high similarity to patient tumor characteristics. Tumor organoids maintain high consistency with patient tumor pathological, molecular, drug sensitivity, and genetic stability features, and can be cultured long-term and stably passaged in vitro. This organoid model has been recommended for clinical guidance of personalized medication therapy, with reported accuracy reaching 80%.
Accurate International Biotechnology (Guangzhou) Co.,Ltd · China
A clinical diagnostic service using organoid technology to perform personalized drug sensitivity testing for cancer patients. This test helps identify optimal anti-tumor drug regimens, improve chemotherapy and targeted therapy efficacy, reduce drug resistance risk, and provide scientific guidance for clinical treatment decisions.
Diatech Pharmacogenetics srl · Italy
Molecular testing service designed to identify genetic variants and decode genomic information for precision medicine applications. Enables tailored treatment selection based on individual patient genetic profiles in oncology and pharmacogenetics.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Precision medicine test identifying optimal chemotherapy agents for individual tumors based on molecular characteristics. Guides targeted drug selection and improves treatment efficacy.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
High-throughput sequencing detection service for tumor-derived circulating free DNA genetic mutations, enabling precise tumor profiling and monitoring. The service has passed national inter-laboratory quality assessments with full marks.
NOROVA · China
Precision diagnostic service utilizing liquid biopsy technology for early detection and monitoring of malignant tumors. Analyzes circulating biomarkers from patient blood samples. Enables non-invasive assessment of tumor characteristics and treatment response.
Life Medical Diagnostics LLC · United Arab Emirates
Advanced molecular diagnostic testing service for genetic and molecular-level analysis of diseases. The service enables precise diagnosis and personalized treatment approaches.
40 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products